Rationale: Previous work indicates that ivacaftor improves cystic fibrosis transmembrane conductance regulator (CFTR) activity and lung function in people with cystic fibrosis and G551D-CFTR mutations but does not reduce density of bacteria or markers of inflammation in the airway. These findings raise the possibility that infection and inflammation may progress independently of CFTR activity once cystic fibrosis lung disease is established. Objectives: To better understand the relationship between CFTR activity, airway microbiology and inflammation, and lung function in subjects with cystic fibrosis and chronic airway infections. Methods: We studied 12 subjects with G551D-CFTR mutations and chronic airway infections before and afte...
Cystic fibrosis (CF), the most common lethal autosomal recessive disease in Caucasians resulting in ...
The advent of Cystic fibrosis transmembrane receptor (CFTR) modulators in 2012 was a critical event ...
AbstractIn most patients with cystic fibrosis (CF) life expectancy is limited due to a progressive l...
Rationale: Previous work indicates that ivacaftor improves cystic fibrosis transmembrane conductance...
In cystic fibrosis (CF) therapy, the recent approval of CF-transmembrane conductance regulator (CFTR...
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, a new series of therapeutics ...
<div><p>Background</p><p>Airway microbiota composition has been clearly correlated with many pulmona...
Rationale: Ivacaftor can greatly improve clinical outcomes in people with cystic fibrosis (CF) and h...
Airway microbiota composition has been clearly correlated with many pulmonary diseases, and notably ...
BACKGROUND: The ability to restore cystic fibrosis transmembrane regulator (CFTR) function with effe...
Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aer...
Defective CFTR biogenesis and activity in cystic fibrosis airways leads to airway dehydration and im...
Rationale: Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator rec...
To the Editor: Cystic fibrosis (CF) is the most common life-shortening genetic disorder in the Cauc...
Cystic fibrosis (CF), the most common genetically inherited disease in Caucasian populations, is a m...
Cystic fibrosis (CF), the most common lethal autosomal recessive disease in Caucasians resulting in ...
The advent of Cystic fibrosis transmembrane receptor (CFTR) modulators in 2012 was a critical event ...
AbstractIn most patients with cystic fibrosis (CF) life expectancy is limited due to a progressive l...
Rationale: Previous work indicates that ivacaftor improves cystic fibrosis transmembrane conductance...
In cystic fibrosis (CF) therapy, the recent approval of CF-transmembrane conductance regulator (CFTR...
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, a new series of therapeutics ...
<div><p>Background</p><p>Airway microbiota composition has been clearly correlated with many pulmona...
Rationale: Ivacaftor can greatly improve clinical outcomes in people with cystic fibrosis (CF) and h...
Airway microbiota composition has been clearly correlated with many pulmonary diseases, and notably ...
BACKGROUND: The ability to restore cystic fibrosis transmembrane regulator (CFTR) function with effe...
Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aer...
Defective CFTR biogenesis and activity in cystic fibrosis airways leads to airway dehydration and im...
Rationale: Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator rec...
To the Editor: Cystic fibrosis (CF) is the most common life-shortening genetic disorder in the Cauc...
Cystic fibrosis (CF), the most common genetically inherited disease in Caucasian populations, is a m...
Cystic fibrosis (CF), the most common lethal autosomal recessive disease in Caucasians resulting in ...
The advent of Cystic fibrosis transmembrane receptor (CFTR) modulators in 2012 was a critical event ...
AbstractIn most patients with cystic fibrosis (CF) life expectancy is limited due to a progressive l...